FINWIRES · TerminalLIVE
FINWIRES

Vector Science and Therapeutics Signs Amended 10-Year Manufacturing and Testing Agreement

By

Vector Science and Therapeutics' (PAIN.V) on Monday said its Vector Science and Therapeutics Operating unit entered into an amended and restated exclusive license and manufacturing agreement with LyoGenesis.

Financial terms of the deal were not disclosed. The amended agreement has an initial term of 10 years, automatically renewing thereafter in successive one-year terms unless cancelled earlier, it said.

LyoGenesis will continue as VST's exclusive manufacturer of its proprietary, lyophilized peptide-based pharmaceutical products at its facility in Wisconsin.

Shares of the company were last seen down C$0.01, or 0.5% to C$2.17 on the TSX Venture Exchange.

Price: $2.17, Change: $-0.01, Percent Change: -0.46%

Related Articles

Mining & Metals

Amapa Minerals Produces About 500 Ounces of Gold in Q2

Amapa Minerals Holdings (AMAP.TO) after the close on Friday said it produced approximately 500 ounces of gold during the second quarter, including about 162 ounces recovered from legacy gold-in-circuit.The company achieved its first gold pour on May 4 and also commenced gold sales, selling 291 ounces and recognizing revenue of $1.2 million in Q2. During the period ended on June 30, the company processed approximately 24,587 tonnes of existing stockpiled material at an average plant feed grade of approximately 0.59 grams of gold per tonne. Metallurgical recovery was approximately 72.2%.Cash and cash equivalents stood at $2.8 million, positive net working capital of $13.7 million and total equity of $135.5 million as of June 30, Amapa said.On July 30, the company closed its initial public offering and its shares started trading on the Toronto Stock Exchange. That time it raised C$140 million from the IPO of 127.3-million shares priced at C$1.10 each.The company's shares closed down C$0.02 to C$1.08 on the Toronto Stock Exchange.

$AMAP.TO
Mining & Metals

Profound Medical Names Matthew Sobczyk Interim CFO as Rashed Dewan Steps Down

Profound Medical (PRN.TO) after trade Friday said Matthew Sobczyk has been promoted from corporate controller to interim chief financial officer, effective immediately.He joined the company in 2020 and replaces Rashed Dewan, who has stepped down as CFO, it added.Dewan would stay with the company on a short-term consulting contract to help ensure a smooth transition, Chief Executive Arun Menawat said.

$PRN.TO
Mining & Metals

Stracon Group Swings to Q2 Profit

Stracon Group (STG.TO) Friday after-trade reported a swing to a second-quarter profit of $0.06 per share, from a loss of $0.02 per share in the prior-year period.The engineering and industrial services company said revenue advanced 6.5% year over year, to $208.3 million. Stracon noted the industrial services segment revenue posted the biggest revenue increase, jumping 21% to $147.9 million from $122.5 million.Stracon Group shares closed unchanged at C$10.52, on the Toronto Stock Exchange

$STG.TO